Next report date
Report period
H1 2024
EPS estimate
0.18EUR
Revenue estimate
41.44 BEUR
0.3715EUR
1.16 BEUR
76.47 BEUR
1.34 B
About SINOPHARM GROUP CO. LTD.
Sector
Industry
Headquarters
Shanghai
Website
Employees (FY)
115.96 K
Founded
2003
FIGI
BBG000VZC5T1
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where X2S is featured.
Frequently Asked Questions
The current price of X2S is 2.5290 EUR — it has decreased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SINOPHARM GROUP CO. LTD. stocks are traded under the ticker X2S.
SINOPHARM GROUP CO. LTD. is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
X2S stock is 0.79% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is SINOPHARM GROUP CO. LTD. there?
X2S earnings for the last quarter are 0.17 EUR per share, whereas the estimation was 0.17 EUR resulting in a −1.49% surprise. The estimated earnings for the next quarter are 0.19 EUR per share. See more details about SINOPHARM GROUP CO. LTD. earnings.
SINOPHARM GROUP CO. LTD. revenue for the last quarter amounts to 38.04 B EUR despite the estimated figure of 37.91 B EUR. In the next quarter revenue is expected to reach 40.00 B EUR.
Yes, you can track SINOPHARM GROUP CO. LTD. financials in yearly and quarterly reports right on TradingView.
X2S stock has risen by 8.45% compared to the previous week, the month change is a 6.84% rise, over the last year SINOPHARM GROUP CO. LTD. has showed a 21.04% decrease.
X2S net income for the last quarter is 620.23 M EUR, while the quarter before that showed 542.91 M EUR of net income which accounts for 14.24% change. Track more SINOPHARM GROUP CO. LTD. financial stats to get the full picture.
Today SINOPHARM GROUP CO. LTD. has the market capitalization of 8.01 B, it has increased by 7.08% over the last week.
Yes, X2S dividends are paid annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 4.18%. Tracking SINOPHARM GROUP CO. LTD. dividends might help you take more informed decisions.
SINOPHARM GROUP CO. LTD. dividend yield was 4.60% in 2023, and payout ratio reached 29.31%. The year before the numbers were 4.54% and 28.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, X2S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINOPHARM GROUP CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 115.96 K employees. See our rating of the largest employees — is SINOPHARM GROUP CO. LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINOPHARM GROUP CO. LTD. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINOPHARM GROUP CO. LTD. stock shows the buy signal. See more of SINOPHARM GROUP CO. LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SINOPHARM GROUP CO. LTD. future price: according to them, X2S price has a max estimate of 3.84 EUR and a min estimate of 2.60 EUR. Read a more detailed SINOPHARM GROUP CO. LTD. forecast: see what analysts think of SINOPHARM GROUP CO. LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINOPHARM GROUP CO. LTD. EBITDA is 3.35 B EUR, and current EBITDA margin is 4.38%. See more stats in SINOPHARM GROUP CO. LTD. financial statements.